Proteinase 3 antineutrophil cytoplasmatic antibodies (PR3-ANCA) have been shown to discriminate patients with ulcerative colitis from those with Crohn’s disease, along with demonstrating disease severity and activity [7]. This evidence concerns the gene PRTN3 and ulcerative colitis.